Nasosinusal polyposis;Polypose nasosinusienne

Presse Medicale

Volumn 30, Issue 39-40, 2001, Pages 44-50

  Crampette, Louis ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CHEMOKINE; CORTICOSTEROID; CYTOKINE; GROWTH FACTOR; INTERLEUKIN 18; LEUKOTRIENE RECEPTOR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ALLERGY; ASTHMA; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DRUG CONTRAINDICATION; EOSINOPHIL; EPITHELIUM CELL; ETHMOIDECTOMY; HUMAN; INFLAMMATION; LONG TERM CARE; NASOSINUSAL POLYP; NOSE POLYP; PATHOPHYSIOLOGY; REVIEW; TREATMENT FAILURE;

EID: 0035936370     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. A clinical and pathologic study of chronic sinusitis: The role of the eosinophil
2. Nasal polyps
3. Mast cell degranulation in nasal polyps
4. The pathogenesis of nasal polyps
5. Infuence of allergy, asthma and hypertension on nasal polyposis
6. The role of allergy in sinusitis in adults
7. Clinical profile and recurrence of nasal polyps
8. Allergy as an etiologic factor in nasal polyposis
9. Nasal polyposis. Relationships to allergy and acetylsalicylic acid intolerance
10. Nasals polyps: Effects of seasonnal allergen exposure
11. Primary nasal polyposis
12. NARES: A model of inflammation caused by activated eosinophils?
13. Pathologic findings in allergic aspergillus sinusitis. A newly recognized form of sinusitis
14. Allergic aspergillus sinusitis: Concepts in diagnosis and treatment of a new clinical entity
15. Bacterial allergy in nasal polyposis. A new method for quantifying specific IgE
16. Importance of allergic etiology in nasal polyposis
17. Lymphocyte subsets and antigen-specific IgE antibody in nasal polyps
18. Interferon gamma expression in human nasal polyps
19. The presence of atopy does not determine the type of cellular infiltrate in nasal polyps
20. Distribution of mast cells and eosinophils in nasal polyps from atopic and non atopic subjects: A morphometric study
21. Cytokine gene expression in nasal polyps
22. Accumulation of interferon gamma producing Th1 helper T cells in nasal polyps
23. Nasal polyposis: In search of a viral etiology using DNA hybridization
24. Nonallergic rhinitis with eosinophilia (NARESyndrome). Clinical and immunologic presentation
25. Allergic and nonallergic rhinitis: Their characterization with attention to the meaning of nasal eosinophilia
26. Le NARES, maillon évolutif de la triade de Fernand-Widal
27. Chronic hyperplastic sinusitis: Association of tissue eosinophilia with RNA expression of granulocyte-macrophage colony stimulating factor and interleukin-3
28. Stimulation of dispersed nasal polyp cells by hyperosmolar solutions
29. The role of allergy in sinusitis in adults
30. Immunohistological characteristics of nasal polyps. A comparison with healthy mucosa and chronic sinusitis
31. Lymphocytes and nonlymphoid cells in human nasal polyps
32. Mast cell quantitation in nasal polyps, sinus mucosa and nasal turbinate mucosa
33. Comparison of arachidonic acid metabolism in nasal polyps and eosinophils
34. Arachidonic acid metabolites in human nasal polyps
35. Evidence of platelet-activating factor in nasal polyps
36. Presence of neuropeptides in human nasal polyps
37. Comparison of the role of nasal polyp and normal nasal mucosal epithelial cells on in vitro eosinophil survival. Mediation by GM CSF and inhibition by dexamethasone
38. Quantification and immunocytological identification of interleukin-1 in nasal polyps from patients with chronic sinusitis
39. GM CSF, IL-5 and RANTES immunoreactivity and mRNA expression in chronic hyperplastic sinusitis with nasal polyposis
40. TNF-alpha production by eosinophils in upper airways inflammation (nasal polyposis)
41. Cytokine gene expression and release from epithelial cells. A comparison study between healthy nasal mucosa and nasal polyps
42. Expression of transforming growth factors-alpha and beta 1 messenger RNA and product by eosinophils in nasal polyps
43. Expression of the transforming growth factor-beta isoforms in inflammatory cells of nasal polyps
44. Insulin-like growth factor 1 is a possible pathogenic mechanism in nasal polyps
45. Expression of basic fibroblast growth factor in nasal polyps
46. Keratinocyte growth factor and its receptor messenger RNA expression in nasal mucosa and nasal polyps
47. Immunocompetent cells in human nasal polyps and normal mucosa
48. Inhibition of mediator and cytokine release from dispersed nasal polyp cells by Terfenadine
49. Stimulation of dispersed nasal polyp cells by hyperosmolar solutions
50. Inhibitory activity of Loratadine and Descarboethoxyloratadine on expression of ICAM-1 and HLA-DR by nasal epithelial cells
51. ICAM-1 expression in upper respiratory mucosa is differencially related to eosinophil and neutrophil inflammation according to the allergic status
52. Formation of mucosal polyps in the nasal and maxillary sinus cavities by infecton
53. Increased ion transport in cultured nasal polyp epithelial cells
54. Decreased expression of the CFTR protein in remodeled human nasal epithelium from non cystic-fibrosis patients
55. Résultats pneumo-allergologiques d'une étude épidemiologique prospective multicentrique francaise (groupe o.r.l.i.) sur les polyposes naso-sinusiennes. Soumis à publication
56. Genetic influences in the formation of nasal polyps
57. Nasal polyps in identical twins
58. Hereditary factor for nasal polyps
59. Le traitement de la polypose naso-sinusienne. Etat de l'art
60. Diagnosis and treatment of nasal polyposis
61. Polypose naso-sinusienne: Traitement médical
62. Treatment of nasal polyps with intranasal bedomethasone dipropionate aerosol
63. The effect of budesonide (Rhinocort*) in the treatment of small and medium-sized nasal polyps
64. Medical treatment of nasal polyps
65. Clinical course of patients with primary nasal polyps
66. Dose-related efficacity and tolerability of fluticasone propionate nasal drops 400 microg once daily and twice daily in the treatment of bilateral nasal polyposis: A placebo-controlled randomized study in adult patients
67. Surgical treatment of nasal polyps: Past, present and future
68. Advances in the medical treatment of nasal polyps
69. Diffuse nasal polyposis: Postoperative long-term results after endoscopic sinus surgery and frontal irrigation
70. Management of nasal polyps: Is objective assessment possible?
71. Endonasal microendoscopic pansinsoperation for chronic sinusitis. Results and complications
72. Comparison of functional results after ethmoidectomy and nasalisation for diffuse and severe nasal polyposis